NR2F1 overexpression
|
Melanoma
|
NR2F1 overexpression
|
Melanoma
|
MEK inhibitor + CDK4 inhibitor Resistant: D – Preclinical
|
MEK inhibitor + CDK4 inhibitor Resistant: D – Preclinical
|
NR2F1 overexpression
|
Melanoma
|
NR2F1 overexpression
|
Melanoma
|
MEK inhibitor + CDK6 inhibitor Resistant: D – Preclinical
|
MEK inhibitor + CDK6 inhibitor Resistant: D – Preclinical
|
NR2F1 overexpression
|
Melanoma
|
NR2F1 overexpression
|
Melanoma
|
BRAF inhibitor + MEK inhibitor Resistant: D – Preclinical
|
BRAF inhibitor + MEK inhibitor Resistant: D – Preclinical
|